Literature DB >> 11734598

Breast carcinoma in situ: risk factors and screening patterns.

E B Claus1, M Stowe, D Carter.   

Abstract

BACKGROUND: Risk factors associated with invasive breast cancer are well documented, but those associated with breast carcinoma in situ are not well defined.
METHODS: We conducted a population-based, case-control study among female residents of Connecticut to identify risk factors for breast carcinoma in situ. Case patients, diagnosed with ductal carcinoma in situ (DCIS) (n = 875) or lobular carcinoma in situ (LCIS) (n = 123), were matched by 5-year age groups with control subjects (n = 999). Case patients were diagnosed between September 15, 1994, through March 14, 1998, and all subjects were between the ages of 20 and 79 years. Information on risk factors and cancer-screening history was collected by telephone interviews. Conditional logistic regression was used to determine odds ratios (ORs) for the association of these factors with the risk of DCIS and LCIS.
RESULTS: Case patients with DCIS were more likely than control subjects to report a family history of breast cancer (OR = 1.48; 95% confidence interval [CI] = 1.19 to 1.85) or previous breast biopsy (OR = 3.56; 95% CI = 2.86 to 4.43). They also had fewer full-term pregnancies (OR = 0.86; 95% CI = 0.80 to 0.93) and were older at first full-term pregnancy (OR for being 20-29 years old relative to being <20 years old = 1.68; 95% CI = 1.17 to 2.43) and at menopause (OR for being > or =55 years old relative to being <45 years old = 1.71; 95% CI = 1.05 to 2.77). DCIS case patients were more likely than control subjects to have had a mammographic examination (OR = 2.46; 95% CI = 1.78 to 3.40) or an annual clinical breast examination (OR = 1.83; 95% CI = 1.48 to 2.26). DCIS patients and control subjects did not differ with respect to oral contraceptive use, hormone replacement therapy, alcohol consumption or smoking history, or breast self-examination. Associations for LCIS were similar.
CONCLUSIONS: The risk factors associated with DCIS and LCIS are similar to those associated with invasive breast cancer. Diagnosis of DCIS is associated with increased mammography screening.

Entities:  

Mesh:

Year:  2001        PMID: 11734598     DOI: 10.1093/jnci/93.23.1811

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  29 in total

1.  Epidemiologic Risk Factors for In Situ and Invasive Breast Cancers Among Postmenopausal Women in the National Institutes of Health-AARP Diet and Health Study.

Authors:  Maeve Mullooly; Zeina G Khodr; Cher M Dallal; Sarah J Nyante; Mark E Sherman; Roni Falk; Linda M Liao; Jeffrey Love; Louise A Brinton; Gretchen L Gierach
Journal:  Am J Epidemiol       Date:  2017-12-15       Impact factor: 4.897

2.  Postmenopausal hormone therapy and ductal carcinoma in situ: a population-based case-control study.

Authors:  Lisa Calvocoressi; Meredith H Stowe; Darryl Carter; Elizabeth B Claus
Journal:  Cancer Epidemiol       Date:  2012-02-06       Impact factor: 2.984

3.  Ductal Carcinoma in Situ: Clinical Perspective.

Authors:  Thorsten Kühn
Journal:  Breast Care (Basel)       Date:  2010-08-02       Impact factor: 2.860

4.  Estrogen Receptor Status and the Future Burden of Invasive and In Situ Breast Cancers in the United States.

Authors:  Philip S Rosenberg; Kimberly A Barker; William F Anderson
Journal:  J Natl Cancer Inst       Date:  2015-06-10       Impact factor: 13.506

5.  Breast cancer stage at diagnosis and geographic access to mammography screening (New Hampshire, 1998-2004).

Authors:  Maria O Celaya; Ethan M Berke; Tracy L Onega; Jiang Gui; Bruce L Riddle; Sai S Cherala; Judy R Rees
Journal:  Rural Remote Health       Date:  2010-04-23       Impact factor: 1.759

6.  Socioeconomic disparities in the decline in invasive breast cancer incidence.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Elizabeth S Burnside
Journal:  Breast Cancer Res Treat       Date:  2010-01-20       Impact factor: 4.872

7.  Full sequencing of TP53 identifies identical mutations within in situ and invasive components in breast cancer suggesting clonal evolution.

Authors:  Wenjing Zhou; Aslaug A Muggerud; Phuong Vu; Eldri U Due; Therese Sørlie; Anne-Lise Børresen-Dale; Fredrik Wärnberg; Anita Langerød
Journal:  Mol Oncol       Date:  2009-04-02       Impact factor: 6.603

8.  Probability estimation models for prediction of BRCA1 and BRCA2 mutation carriers: COS compares favourably with other models.

Authors:  Hassan Roudgari; Zosia H Miedzybrodzka; Neva E Haites
Journal:  Fam Cancer       Date:  2007-12-21       Impact factor: 2.375

9.  Reproductive and hormonal risk factors for ductal carcinoma in situ of the breast.

Authors:  Lynette S Phillips; Robert C Millikan; Jane C Schroeder; Jill S Barnholtz-Sloan; Beverly J Levine
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-05       Impact factor: 4.254

10.  Risk factors for young-onset invasive and in situ breast cancer.

Authors:  Katie M O'Brien; Jenny Sun; Dale P Sandler; Lisa A DeRoo; Clarice R Weinberg
Journal:  Cancer Causes Control       Date:  2015-09-25       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.